Logo
Whalesbook
HomeNewsCorporate NewsPremiumStocks
HomeNewsCorporate NewsPremiumStocks

Raaj Medisafe India Ltd

₹ 94.00.00%
16 Jan – close price
🔗raajmedisafeindia.com•BSE: 524502•NSE:
Market Cap₹ 124 Cr.
Current Price₹ 94.0
High / Low₹ 102
Stock P/E16.1
Book Value₹ 22.0
Dividend Yield0.00 %
ROCE15.0 %
ROE32.5 %
Face Value₹ 10.0
Sales₹ 73.2 Cr.
OPM14.6 %
Mar Cap₹ 124 Cr.

ABOUT

Incorporated in 1985, Raaj Medisafe India Ltd manufactures plastic bottles, caps & plugs, plastic liners and aluminum caps

KEY POINTS

Product Profile:[1][2]a) Plastic Bottlesb) Caps & Plugsc) Plastic Linersd) Aluminum Capse) Disposable Syringesf) Intravenous Setsg) Packed Needles

Also present in buckets:
Aggressive Growth TriggersExcellent ResultsRevenue GuidanceAsset Base ExpansionCapacity Expansion And ProductsPreferential IssuanceOrder Book PositionLarge Order ReceiptsJv Partnerships AcquisitionsCredit Rating UpdatesRed Flags And Poor Performance

Peer Comparision

S.No.NameCurrent Price (Rs.)Price to EarningMarket Capitalization (Rs.Cr.)Dividend yield (%)Net Profit latest quarter (Rs.Cr.)YOY Quarterly profit growth (%)Sales latest quarter (Rs.Cr.)YOY Quarterly sales growth (%)Return on capital employed (%)Sales (Rs.Cr.)OPM (%)Profit after tax (Rs.Cr.)Profit after tax latest quarter (Rs.Cr.)Price to book valueReturn on assets (%)Debt to equity
1.EPL Ltd207.7816.026656.402.41106.1019.891205.9011.0217.484433.5020.48415.43104.302.539.490.32
2.AGI Greenpac669.9512.314334.401.0476.125.60601.580.4019.892652.5523.18352.1076.121.959.270.21
3.Uflex470.3510.713395.750.6426.85583.993832.03-0.047.7515281.5511.15317.2026.910.441.311.21
4.Polyplex Corpn871.8537.262729.971.5533.50-71.871794.043.177.166993.434.1073.2724.700.684.640.24
5.XPRO India1100.90191.262587.780.184.97-50.00119.91-10.507.93527.574.8113.534.973.774.600.46
6.TCPL Packaging2805.8020.472549.951.0728.33-20.89437.70-0.1820.031714.4016.28124.5728.333.799.790.97
7.Mold-Tek Pack.578.4528.661925.240.6915.489.71209.769.6512.41843.6218.7367.1815.482.886.880.33
8.Raaj Medisafe94.0016.13124.200.001.7378.3518.4068.6515.0273.2214.617.701.734.2711.101.79
–Median: 47 Co.149.8619.59421.290.325.1719.43115.7110.211.5409.569.617.094.971.815.140.33

Quarterly Results

Standalone figures in ₹ crores

Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
Sales
9.229.559.6610.5211.2010.1711.3610.9110.9114.5924.4015.8318.40
Expenses
7.727.958.179.319.638.659.049.189.1812.3721.2913.2115.65
Operating Profit
1.501.601.491.211.571.522.321.731.732.223.112.622.75
Other Income
0.01-0.010.010.010.010.000.040.000.00-0.010.110.010.23
Profit before tax
1.061.091.000.631.050.941.661.141.141.292.101.461.73
Tax %
0.00%0.00%44.00%0.00%0.00%0.00%57.83%15.79%15.79%19.38%-65.24%0.00%0.00%
Net Profit
1.071.090.560.631.060.940.700.970.971.033.481.461.73
EPS in Rs
0.981.000.510.580.970.860.640.730.730.782.631.111.31

Profit & Loss

Standalone Figures in ₹ Crores / Yearly

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Sales
0.000.001.804.424.624.8021.8031.8034.6838.6143.2462.4273.22
Expenses
0.220.612.114.505.075.5820.2927.7429.6033.0036.6053.7962.52
Operating Profit
-0.22-0.61-0.31-0.08-0.45-0.781.514.065.085.616.648.6310.70
Other Income
-0.010.040.010.030.000.250.340.010.080.020.060.200.34
Interest
0.050.370.540.510.660.751.160.740.711.111.572.132.70
Depreciation
0.190.250.240.270.310.310.680.710.720.750.841.451.76
Profit before tax
-0.47-1.19-1.08-0.83-1.42-1.590.012.623.733.774.295.256.58
Net Profit
-0.48-1.19-1.08-0.83-1.43-1.59-0.292.303.013.333.336.137.70
EPS in Rs
-0.95-2.36-2.14-1.65-2.84-3.15-0.582.102.753.043.044.645.83
Dividend Payout %
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%–

Compounded Sales Growth

10 Years:%
5 Years:23%
3 Years:22%
TTM:69%

Compounded Profit Growth

10 Years:22%
5 Years:73%
3 Years:27%
TTM:115%

Stock Price CAGR

10 Years:29%
5 Years:56%
3 Years:42%
1 Year:32%

Return on Equity

10 Years:%
5 Years:%
3 Years:38%
Last Year:32%

Balance Sheet

Standalone figures in ₹ crores

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
5.005.005.005.005.005.0010.9010.9010.9010.9010.9013.1813.15
Reserves
-6.49-7.96-9.03-9.88-11.32-12.91-12.09-9.83-6.75-3.41-0.0713.7415.96
Borrowings
4.107.107.619.039.4311.6111.8713.1313.0215.6225.9334.5752.16
Other Liabilities
0.120.251.661.622.071.422.912.412.452.664.527.727.87
Total Liabilities
2.734.395.245.775.185.1213.5916.6119.6225.7741.2869.2189.14
Fixed Assets
1.413.303.573.493.473.487.037.269.308.6310.7223.0629.38
Gross Block
7.377.185.025.215.505.8313.1613.6616.3616.3619.2832.96–
Accumulated Depreciation
5.963.881.451.722.032.356.146.407.067.728.559.90–
CWIP
0.280.000.000.540.000.000.001.600.001.5910.148.5115.97
Investments
0.000.010.010.010.010.010.070.070.070.070.070.070.07
Other Assets
1.041.081.661.731.701.636.497.6810.2515.4820.3537.5743.72
Total Assets
2.734.395.245.775.185.1213.5916.6119.6225.7741.2869.2189.14

Cash Flows

Standalone Figures in ₹ Crores / Yearly

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Cash from Operating Activity
-0.98-0.180.14-0.23-0.01-1.37-1.032.232.450.174.27-0.09
Cash from Investing Activity
-0.39-2.14-0.51-0.680.27-0.05-0.21-2.78-0.96-1.67-13.00-16.42
Cash from Financing Activity
1.392.63-0.020.92-0.261.431.240.51-1.471.498.7416.52
Net Cash Flow
0.020.31-0.390.010.000.000.00-0.040.02-0.010.020.02

Ratios

Standalone Figures in ₹ Crores / Yearly

Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days
––115.5835.5160.8362.3578.6956.2457.2564.7666.6097.65
Inventory Days
–2,555.00106.92141.1398.6164.6120.9624.6548.1889.79105.5067.86
Days Payable
–5,475.00538.28233.60275.22132.6251.5619.466.6610.608.8535.77
Cash Conversion Cycle
––-315.78-56.96-115.78-5.6648.1061.4398.77143.95163.24129.75
Working Capital Days
––-56.78-87.53-141.42-123.95-7.538.724.8436.4021.619.88
ROCE %
-16.47%-23.41%-13.99%-9.06%-20.94%-32.01%16.41%27.09%27.99%24.23%19.58%15.02%

Shareholding Pattern

Numbers in percentages

Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025
Promoters
73.45%73.45%73.45%73.45%73.45%73.45%73.45%73.45%73.45%73.45%73.45%73.80%
FIIs
––––––––––––
DIIs
––––––––––––
Public
26.54%26.55%26.56%26.56%26.54%26.56%26.56%26.55%26.56%26.55%26.55%26.20%

* The classifications might have changed from Sep'2022 onwards.ℹ️

BSE Announcements AI Summary

Direct from BSE filings, auto-summarised

Raaj Medisafe India Submits SEBI Compliance Certificate for Q4 FY26

10th April 2026, 9:21 pm

Raaj Medisafe India Approves Preferential Allotment of 32.75 Lakh Shares

26th March 2026, 10:01 pm

Raaj Medisafe India Board Meeting on March 26, 2026, to Consider Preferential Share Allotment

20th March 2026, 8:00 pm

Raaj Medisafe India Ltd. Files Unaudited Financial Results Publication

13th February 2026, 7:10 pm

Raaj Medisafe India Limited: Q3 FY26 Results - Strong YoY Growth in Revenue and Net Profit, Corrigendum Issued

12th February 2026, 6:55 pm

Published by Other Websites

External media mentions & references

Sub-Rs 100 Stocks Surge: Buyers Dominate Dozen Penny Shares

12th January 2026, 4:28 pm

Raaj Medisafe Posts 42% Revenue Surge, But Soaring Finance Costs Spark Concern
Raaj Medisafe Board to Consider Preferential Equity Share Allotment
Raaj Medisafe Raises ₹18 Cr via Preferential Allotment at ₹55

News Articles

Editorial & research coverage

Sub-Rs 100 Stocks Surge: Buyers Dominate Dozen Penny Shares
Sub-Rs 100 Stocks Surge: Buyers Dominate Dozen Penny Shares

12th January 2026, 4:28 pm

Raaj Medisafe Posts 42% Revenue Surge, But Soaring Finance Costs Spark Concern
Raaj Medisafe Posts 42% Revenue Surge, But Soaring Finance Costs Spark Concern

Documents

Announcements

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

5h - Certificate under Regulation 74 (5) of SEBI (DP) Regulation for the quarter ended December 31, 2025

Announcement under Regulation 30 (LODR)-Newspaper Publication

27 Dec - News Paper cutting for Publication of Notice of intimation of EGM to be held on 20th day of January, 2026.

Extraordinary General Meeting To Be Held On January 20, 2026
Closure of Trading Window

24 Dec - Trading window closed Jan 1, 2026 until 48 hours after unaudited Q3 (Dec 31, 2025) results declaration.

Announcement under Regulation 30 (LODR)-Meeting Updates

23 Dec - Raaj Medisafe to acquire Fabrizo's plant, machinery and business for Rs.28 crore; completion by Dec 31, 2025.

Annual Reports

Financial Year 2025

(from bse)

Financial Year 2024

(from bse)

Financial Year 2023

(from bse)

Financial Year 2022

(from bse)

Financial Year 2021

(from bse)

Financial Year 2020

(from bse)

Financial Year 2019

(from bse)

Financial Year 2018

(from bse)

Financial Year 2017

(from bse)

Financial Year 2016

(from bse)

Financial Year 2015

(from bse)

Financial Year 2014

(from bse)

Financial Year 2013

(from bse)

Financial Year 2012

(from bse)

Financial Year 2011

(from bse)

Credit Ratings

Rating update

8 Oct 2025 from fitch

Rating update

1 Aug 2024 from fitch

Concalls

No concalls.

Stock Analysis

Description

Raaj Medisafe India Ltd, founded in 1985, is engaged in manufacturing plastic bottles, caps & plugs, plastic liners, and aluminum caps. The company also produces disposable syringes, intravenous sets, and packed needles.

Key Growth Triggers

  1. Planned acquisition of Fabrizo Industries for ₹28 crore to boost alcobev packaging segment.
  2. Significant fundraising of ₹180.125 crore through preferential allotment to support expansion and acquisition plans.
  3. Expansion of manufacturing capacities to drive future growth.
  4. Recent strong year-on-year growth in revenue and net profit observed in quarterly results.

Order Book

Currently no data available for Order Book.

Key Red Flags

  1. High Debt-to-Equity ratio (1.79 as of March 2025) indicates substantial financial leverage.
  2. Negative operating cash flow reported for the period ending March 2025.

Key Dates To Watch

  1. Extraordinary General Meeting (EGM) scheduled for January 20, 2026, to seek shareholder approval for strategic expansion and fundraising initiatives.

Corporate Announcements

10th Apr 26
Impact Rating: 3
Raaj Medisafe India Limited has submitted the confirmation certificate from its Registrar and Share Transfer Agent for Regulation 74(5) of SEBI, covering the quarter ended March 31, 2026, confirming compliance with dematerialization rules.
26th Mar 26
Impact Rating: 7
Raaj Medisafe India's board approved the allotment of 32,75,000 equity shares at ₹55 each (including ₹45 premium) on a preferential basis for cash consideration.
20th Mar 26
Impact Rating: 7
A board meeting of Raaj Medisafe India Limited is scheduled for March 26, 2026, at 3:45 PM to review previous minutes and consider the preferential allotment of 32,75,000 equity shares.
13th Feb 26
Impact Rating: -
No description available.
12th Feb 26
Impact Rating: 7
Raaj Medisafe India Limited's Q3 FY26 results reveal a significant 41.9% YoY revenue jump and an 84.8% YoY net profit surge, with EPS growing 89.5% YoY. A corrigendum was also filed.